Vanda Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Vanda Pharmaceuticals has a total shareholder equity of $544.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $648.4M and $103.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$388.26m |
| Equity | US$544.91m |
| Total liabilities | US$103.53m |
| Total assets | US$648.44m |
Recent financial health updates
No updates
Recent updates
Vanda Pharmaceuticals: Fanapt Bipolar Win Doesn't Change Much
Apr 05Vanda Pharmaceuticals' (NASDAQ:VNDA) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Feb 15
Vanda Pharmaceuticals' Portfolio Likely Has Upside From 2024 Approvals, Underpinned By Cash
Feb 13Vanda Pharmaceuticals Inc.'s (NASDAQ:VNDA) Low P/S No Reason For Excitement
Feb 10News Flash: One Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Analyst Has Been Trimming Their Revenue Forecasts
Nov 11One Forecaster Is Now More Bearish On Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Than They Used To Be
May 12Vanda Pharmaceuticals: What The Recent Partnership Entails
Oct 06Vanda Pharma, OliPass collaborate to develop oligonucleotide-based therapeutics
Sep 29Vanda Pharmaceuticals Q2 Earnings Preview
Aug 02Vanda Pharmaceuticals: Strong Pipeline Developments To Power Long-Term Upside
May 17Vanda: A Dual Growth And Value Player
Apr 11Financial Position Analysis
Short Term Liabilities: VNDA's short term assets ($432.9M) exceed its short term liabilities ($87.7M).
Long Term Liabilities: VNDA's short term assets ($432.9M) exceed its long term liabilities ($15.8M).
Debt to Equity History and Analysis
Debt Level: VNDA is debt free.
Reducing Debt: VNDA has not had any debt for past 5 years.
Debt Coverage: VNDA has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: VNDA has no debt, therefore coverage of interest payments is not a concern.